This shows you the differences between two versions of the page.
home:patients:protocol_overview [06.21.2019] – [Introduction to the Marshall Protocol] sallieq | home:patients:protocol_overview [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 5: | Line 5: | ||
- | The Marshall Protocol, sometimes referred to as the MP, was developed by a team led by Trevor Marshall, PhD, as an antimicrobial treatment for chronic inflammatory diseases. Most diseases of unknown cause are chronic inflammatory diseases, and almost 100% of patients with these diseases have responded to the treatment. On this site and others, chronic inflammatory diseases are sometimes referred to as the Th1 diseases. | + | The Marshall Protocol, sometimes referred to as the MP, was developed by a team led by Trevor Marshall, PhD, as an antimicrobial treatment for chronic inflammatory diseases. Most diseases of unknown cause are chronic inflammatory diseases, and over 85% of patients with these diseases have responded to the treatment. On this site and others, chronic inflammatory diseases are sometimes referred to as the Th1 diseases. |
Treatment on the MP requires a [[home: | Treatment on the MP requires a [[home: | ||
Line 12: | Line 12: | ||
1 take a minimum 40mg olmesartan (Benicar) every 4-6 hours; | 1 take a minimum 40mg olmesartan (Benicar) every 4-6 hours; | ||
- | 2 avoid as far as possible | + | 2 avoid inter-personal |
3 avoid the consumption of vitamin D, as well as certain other immunosuppressive foods; | 3 avoid the consumption of vitamin D, as well as certain other immunosuppressive foods; | ||
4 wean off any immunosuppressive or potentially immunosuppressive therapies; | 4 wean off any immunosuppressive or potentially immunosuppressive therapies; | ||
Line 110: | Line 110: | ||
+ | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
Line 118: | Line 119: | ||
* | * | ||
* | * | ||
- | ===== References ===== | + | ===== References ===== </ |